melanoma cell trang 3 tải miễn phí từ TAILIEUCHUNG

"melanoma cell" trang 3 - tải miễn phí từ Tailieuchung

Báo cáo hóa học:

Báo cáo hóa học: " Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032"

11 32 0

Báo cáo sinh học:

Báo cáo sinh học: "Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations"

13 34 0

Báo cáo sinh học:

Báo cáo sinh học: " Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow"

14 32 0

báo cáo hóa học:

báo cáo hóa học:" Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow "

14 32 0

báo cáo hóa học:

báo cáo hóa học:" Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations"

13 36 0

Báo cáo khoa học:

Báo cáo khoa học: " Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control"

8 39 0

Pharmacotherapy of Sickle Cell Disease

Pharmacotherapy of Sickle Cell Disease

16 41 0

Báo cáo khoa học: Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells

Báo cáo khoa học: Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells

9 53 0

Báo cáo Y học: Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells deﬁne structural determinants of receptor function

Báo cáo Y học: Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells deﬁne structural determinants of receptor function

9 42 0

Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf

Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf

10 58 1

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

12 41 1

Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

11 65 1

Antitumour responses induced by a cellbased Reovirus vaccine in murine lung and melanoma models

Antitumour responses induced by a cellbased Reovirus vaccine in murine lung and melanoma models

10 24 1

Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival

Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival

15 65 1

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

10 20 1

$DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts$

DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts

9 38 1

Effect of low frequency magnetic fields on melanoma: Tumor inhibition and immune modulation

Effect of low frequency magnetic fields on melanoma: Tumor inhibition and immune modulation

11 44 1

Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model

Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model

11 26 1

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

8 20 1

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

9 32 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.